Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239034 (US10028934, Compound 23 | US10478423, Cpd. 23 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239038 (US10028934, Compound 27 | US10478423, Cpd. 27 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239043 (US10028934, Compound 20 | US10478423, Cpd. 20 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239033 (US10028934, Compound 19 | US10478423, Cpd. 19 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239023 (US10028934, Compound 32 | US10478423, Cpd. 32 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239030 (US10028934, Compound 16 | US10478423, Cpd. 16 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239029 (US10028934, Compound 15 | US10478423, Cpd. 15 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239040 (US10028934, Compound 14 | US10478423, Cpd. 14 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239017 (US10028934, Compound 11 | US10478423, Cpd. 11 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239042 (US10028934, Compound 42 | US10478423, Cpd. 42 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239026 (US10028934, Compound 40 | US10478423, Cpd. 40 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239022 (US10028934, Compound 33 | US10478423, Cpd. 33 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239012 (US10028934, Compound 10 | US10478423, Cpd. 10 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239041 (US10028934, Compound 41 | US10478423, Cpd. 41 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 52 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239019 (US10028934, Compound 22 | US10478423, Cpd. 22 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239024 (US10028934, Compound 34 | US10478423, Cpd. 34 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239028 (US10028934, Compound 39 | US10478423, Cpd. 39 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239031 (US10028934, Compound 17 | US10478423, Cpd. 17 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239036 (US10028934, Compound 25 | US10478423, Cpd. 25 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 74 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239037 (US10028934, Compound 26 | US10478423, Cpd. 26 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 90 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239018 (US10028934, Compound 21 | US10478423, Cpd. 21 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 104 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239039 (US10028934, Compound 28 | US10478423, Cpd. 28 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 136 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239035 (US10028934, Compound 24 | US10478423, Cpd. 24 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 162 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239025 (US10028934, Compound 30 | US10478423, Cpd. 30 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 166 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239011 (US10028934, Compound 6 | US10478423, Cpd. 6 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 248 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239010 (US10028934, Compound 7 | US10478423, Cpd. 7 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 249 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239032 (US10028934, Compound 18 | US10478423, Cpd. 18 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 414 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239009 (US10028934, Compound 1 | US10478423, Cpd. 1 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 428 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239021 (US10028934, Compound 38 | US10478423, Cpd. 38 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 539 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239020 (US10028934, Compound 29 | US10478423, Cpd. 29 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 635 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239014 (US10028934, Compound 3 | US10478423, Cpd. 3 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 639 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239015 (US10028934, Compound 4 | US10478423, Cpd. 4 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 974 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239013 (US10028934, Compound 2 | US10478423, Cpd. 2 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.13E+3 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239008 (US10028934, Compound 5 | US10478423, Cpd. 5 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.17E+3 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239027 (US10028934, Compound 35 | US10478423, Cpd. 35 | US...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239016 (US10028934, Compound 9 | US10478423, Cpd. 9 | US94...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor-type tyrosine-protein kinase FLT3 [564-993] (Homo sapiens (Human)) | BDBM239044 (US10478423, Ref. Compound | US9408850, Ref. Compou...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.18E+3 | n/a | n/a | n/a | n/a | 7.9 | 28 |
NERVIANO MEDICAL SCIENCES S.R.L. US Patent | Assay Description The assay was performed using FLT3 cytoplasmic domain product and purified in house as GST fused protein. The FLT3 protein (1 microM) was pre activat... | US Patent US9408850 (2016) BindingDB Entry DOI: 10.7270/Q2F47N2F | |||||||||||
More data for this Ligand-Target Pair |